BKD Brookdale Senior Living Inc.

$11.95 +0.17%

Updated 16 d ago

Healthcare · Services-Nursing & Personal Care Facilities

Brookdale Senior Living Inc. (BKD) is a healthcare company in the Services-Nursing & Personal Care Facilities industry, with a market capitalization of $2.9 billion. Shares last traded at $11.95, 33.6% below their 52-week high. Over the past year the stock is up 56.7%. Net profit margin is -4.5%, below the peer median of -1.5%. Revenue grew 2.2% year over year.

Market Cap

$2.9B

Shares Out

238.8M

EPS (TTM)

$-1.37

P/E Ratio

—

P/S Ratio

0.94

P/B Ratio

—

Dividend / Share

—

Dividend Yield

—

52-Week High

$18.00

52-Week Low

$7.33

Volume

243,933

Avg Vol (3m)

368,938.349

Performance

-1.16%

-17.07%

+0.42%

-18.82%

YTD

+10.34%

+56.72%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

35.18

SMA (50)

$13.95

SMA (200)

$13.32

Price vs SMA50

-14.35%

Price vs SMA200

-10.31%

ATR (14)

$0.82

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$3.1B

Net Income

$-138M

Gross Margin

26.9%

Operating Margin

3.5%

Net Margin

-4.5%

Return on Equity

477.4%

Return on Assets

-2.3%

Current Ratio

1.14

Debt / Equity

-147.46

Revenue Growth (YoY)

+2.2%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$0.07	2026-08-10
Q1 2026	$-0.03	2026-05-07
FY 2025	$-1.12	2026-02-19
Q3 2025	$-0.95	2025-11-07
Q2 2026	$-0.46	2026-08-10
Q1 2026	$-0.28	2026-05-07

Full earnings history →

Healthcare peers

BKD vs 14 sector peers (Healthcare), by market cap. Updated 16 d ago

P/S vs peers

0.94 / 4.47 med

-79% discount

Net margin vs peers

-4.5% / -1.5% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.09T	40.86	13.70	33.5%	-0.02%
JNJ	Johnson & Johnson	$670.6B	31.88	6.85	21.5%	+1.04%
ONC	Beone Medicines Ltd.	$535.9B	817.25	87.43	10.7%	+0.23%
ABBV	AbbVie	$459.8B	72.87	7.14	9.8%	-0.57%
MRK	Merck	$375.8B	118.44	5.65	4.8%	+0.44%
AMGN	Amgen	$240.1B	27.47	6.30	23.0%	+0.31%
TMO	Thermo Fisher Scientific	$228.7B	32.82	4.94	15.0%	+1.66%
KLAC	KLA Corporation	$225.9B	46.76	16.64	35.6%	+0.37%
ABT	Abbott Laboratories	$189.5B	30.20	4.20	13.9%	-1.50%
GILD	Gilead Sciences	$187.5B	-57.87	6.16	-10.6%	+1.09%
PFE	Pfizer	$164.2B	37.91	2.58	6.8%	-0.76%
DHR	Danaher Corporation	$148.3B	37.05	5.91	15.9%	+0.49%
VRTX	Vertex Pharmaceuticals	$141.5B	32.11	11.24	35.0%	+0.24%
BMY	Bristol Myers Squibb	$139.1B	14.98	2.83	18.9%	+0.62%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.